EUVIMEDEUVIMED entdecken
Crossref

In Silico Study of Sesquiterpene and Monoterpene Compounds from Valerian Roots (Valerian officinalis) As Acetylcholinesterase Inhibitor

Shannon Maidelaine Prijadi, Safira Aulia, Auliya Afinasari, Levina Aristawidya, Muhammad Dimas Syahrul Hikam, Muchtaridi Muchtaridi

Indonesian Journal of Computational Biology (IJCB) · 2022

DOI: 10.24198/ijcb.v1i1.35898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indonesian Journal of Computational Biology (IJCB), 2022. Verfasst von Shannon Maidelaine Prijadi und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Alzheimer's is a central nervous system disease that can be treated with an acetylcholinesterase enzyme inhibitor drug (AChE), namely rivastigmine. Rivastigmine has side effects such as nausea, vomiting, loss of appetite, headache, weakness, and malaise. Alternative to deal with these side effects is an extracted compound from valerian root with bioactivity as an anti-dementia. The test compounds that performed the activity were 4 variations of sesquiterpenoids (volvalerenal H, volvalerenal I, volvalerenal J, volvalerenic acid K) and 1 monoterpenoid (densispicnins C).

Objective

This study aimed to determine the molecular interaction of sesquiterpene and monoterpene compounds and pharmacokinetic of the best compound from molecular docking.

Methods

This study was conducted with the stages of molecular docking simulation, prediction of pharmacokinetics and toxicity of compounds, and Lipinski’s Rule of Five parameters.

Result

Volvalerenal J was the best compound from molecular docking simulation with a Gibbs free energy value of -7,48 kcal/mol, an inhibition constant of 1,30 μM, and interactions with amino acid residues His447 and Ser203. The values of HIA and CaCo2 were 100% and 46,76%, with the values of PPB and BBB were 96,57% and 0,88%. Respectively, volvalerenal J is not mutated but a carcinogen and fulfills the rules of Lipinski.

Conclusion

Compound volvalerenal J has the highest potential to be the best acetylcholinesterase (AChE) inhibitor among other compounds in the extract valerian root.Keywords: AChE, Valerian Root, Alzheimer's, In silico

Zitieren

APA

Prijadi, S. M., Aulia, S., Afinasari, A., Aristawidya, L., Hikam, M. D. S., & Muchtaridi, M. (2022). In Silico Study of Sesquiterpene and Monoterpene Compounds from Valerian Roots (Valerian officinalis) As Acetylcholinesterase Inhibitor. Indonesian Journal of Computational Biology (IJCB). https://doi.org/10.24198/ijcb.v1i1.35898

Vancouver

Prijadi SM, Aulia S, Afinasari A, Aristawidya L, Hikam MDS, Muchtaridi M. In Silico Study of Sesquiterpene and Monoterpene Compounds from Valerian Roots (Valerian officinalis) As Acetylcholinesterase Inhibitor. Indonesian Journal of Computational Biology (IJCB). 2022. doi:10.24198/ijcb.v1i1.35898

BibTeX
@article{Prijadi2022,
  author = {Prijadi, Shannon Maidelaine and Aulia, Safira and Afinasari, Auliya and Aristawidya, Levina and Hikam, Muhammad Dimas Syahrul and Muchtaridi, Muchtaridi},
  title = {In Silico Study of Sesquiterpene and Monoterpene Compounds from Valerian Roots (Valerian officinalis) As Acetylcholinesterase Inhibitor},
  journal = {Indonesian Journal of Computational Biology (IJCB)},
  year = {2022},
  doi = {10.24198/ijcb.v1i1.35898}
}
Kostenlos starten →